跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 9,712 条关于
“Akt/mTOR”
全部
9,712
临床试验
6,936
药物
648
机构
82
资讯
2,046
去年
Faeth Therapeutics Advances Novel Three-Pronged Approach for Metabolism-Driven Cancers with Promising Preclinical Results
7个月前
Sensei Biotherapeutics Acquires Faeth Therapeutics for $200M to Advance PI3K/AKT/mTOR Pathway Inhibitor PIKTOR
去年
Ryvu Therapeutics Discovers Synergistic mTOR-AKT Inhibitor Combination for Colorectal Cancer Treatment
上个月
Advanced Endometrial Cancer Pipeline Gains Momentum as ADCs, Immunotherapy and Targeted Combinations Reshape Treatment
去年
Cosmos Health Acquires Rights to Two Patented Anticancer Drugs Targeting Multiple Cancers
去年
Celcuity Secures $500 Million Credit Facility Following Positive Phase 3 Data for Gedatolisib in Advanced Breast Cancer
去年
Dual mTORC1/2 Inhibitor BI 860585 Shows Promise in Phase I Breast Cancer Trial
去年
Celcuity Secures Patent Extension for Gedatolisib Through 2042, Strengthening Breast Cancer Drug Portfolio
11个月前
Faeth Therapeutics Raises $25M to Advance PIKTOR Therapy After 80% Response Rate in Endometrial Cancer
11个月前
Faeth Therapeutics Reports Positive Phase 2 Results for Sapanisertib in Ovarian Cancer Treatment
第 1 页,共 205 页
上一页
下一页